Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Buy
52
STAA Quote, Financials, Valuation and Earnings
Last price:
$26.58
Seasonality move
:
5.07%
Day range:
$26.18 - $26.93
52-week range:
$13.50 - $30.81
Dividend yield:
0%
P/E ratio:
49.73x
P/S ratio:
5.73x
P/B ratio:
3.71x
Volume:
604.4K
Avg. volume:
839K
1-year change:
2.5%
Market cap:
$1.3B
Revenue:
$313.9M
EPS (TTM):
-$1.96
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
STAA
STAAR Surgical Co.
|
$89.4M | $0.28 | 57.14% | 39.51% | $25.88 |
|
COO
The Cooper Cos., Inc.
|
$1.1B | $1.11 | 6.03% | 93.61% | $82.25 |
|
KIDS
OrthoPediatrics Corp.
|
$62M | -$0.26 | 12.55% | -53.5% | $24.14 |
|
LUCY
Innovative Eyewear, Inc.
|
$1M | -$0.49 | 73.74% | -50.4% | $3.00 |
|
NXGL
NexGel, Inc.
|
$3.2M | -$0.08 | 6.54% | -22.68% | $6.00 |
|
PAHC
Phibro Animal Health Corp.
|
$345.4M | $0.60 | 15% | 756.68% | $43.00 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
STAA
STAAR Surgical Co.
|
$26.60 | $25.88 | $1.3B | 49.73x | $0.00 | 0% | 5.73x |
|
COO
The Cooper Cos., Inc.
|
$77.03 | $82.25 | $15.3B | 37.92x | $0.01 | 0% | 3.82x |
|
KIDS
OrthoPediatrics Corp.
|
$18.17 | $24.14 | $455.7M | -- | $0.00 | 0% | 1.87x |
|
LUCY
Innovative Eyewear, Inc.
|
$1.47 | $3.00 | $7.9M | -- | $0.00 | 0% | 2.00x |
|
NXGL
NexGel, Inc.
|
$1.64 | $6.00 | $13.4M | -- | $0.00 | 0% | 1.07x |
|
PAHC
Phibro Animal Health Corp.
|
$40.77 | $43.00 | $1.7B | 24.51x | $0.12 | 1.18% | 1.19x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
STAA
STAAR Surgical Co.
|
9.96% | 0.980 | 2.95% | 4.10x |
|
COO
The Cooper Cos., Inc.
|
22.88% | 0.349 | 17.63% | 0.96x |
|
KIDS
OrthoPediatrics Corp.
|
22.39% | -0.034 | 21.68% | 3.39x |
|
LUCY
Innovative Eyewear, Inc.
|
1.01% | 5.608 | 1.04% | 9.17x |
|
NXGL
NexGel, Inc.
|
38.1% | -0.508 | 15.76% | 0.82x |
|
PAHC
Phibro Animal Health Corp.
|
71.58% | 2.736 | 47.87% | 1.12x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
STAA
STAAR Surgical Co.
|
$76.6M | $44.5M | -23.38% | -25.83% | 46.96% | $1.8M |
|
COO
The Cooper Cos., Inc.
|
$642M | $175.7M | 3.79% | 5% | 16.57% | $164.5M |
|
KIDS
OrthoPediatrics Corp.
|
$40M | -$4.9M | -10.3% | -12.83% | -7.95% | -$3.4M |
|
LUCY
Innovative Eyewear, Inc.
|
$244.8K | -$1.9M | -79.57% | -80% | -287.5% | -$1.5M |
|
NXGL
NexGel, Inc.
|
$1.2M | -$725K | -33.25% | -51.15% | -24.71% | -$793K |
|
PAHC
Phibro Animal Health Corp.
|
$119.3M | $47.9M | 6.8% | 24.77% | 13.16% | -$4.5M |
STAAR Surgical Co. vs. Competitors
-
Which has Higher Returns STAA or COO?
The Cooper Cos., Inc. has a net margin of 9.38% compared to STAAR Surgical Co.'s net margin of 9.27%. STAAR Surgical Co.'s return on equity of -25.83% beat The Cooper Cos., Inc.'s return on equity of 5%.
Company Gross Margin Earnings Per Share Invested Capital STAASTAAR Surgical Co.80.89% $0.18 $392.9M COOThe Cooper Cos., Inc.60.55% $0.49 $10.8B -
What do Analysts Say About STAA or COO?
STAAR Surgical Co. has a consensus price target of $25.88, signalling downside risk potential of -2.73%. On the other hand The Cooper Cos., Inc. has an analysts' consensus of $82.25 which suggests that it could grow by 6.78%. Given that The Cooper Cos., Inc. has higher upside potential than STAAR Surgical Co., analysts believe The Cooper Cos., Inc. is more attractive than STAAR Surgical Co..
Company Buy Ratings Hold Ratings Sell Ratings STAASTAAR Surgical Co.1 10 0 COOThe Cooper Cos., Inc.6 6 1 -
Is STAA or COO More Risky?
STAAR Surgical Co. has a beta of 1.008, which suggesting that the stock is 0.806% more volatile than S&P 500. In comparison The Cooper Cos., Inc. has a beta of 1.048, suggesting its more volatile than the S&P 500 by 4.779%.
-
Which is a Better Dividend Stock STAA or COO?
STAAR Surgical Co. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. The Cooper Cos., Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.01 per share. STAAR Surgical Co. pays -- of its earnings as a dividend. The Cooper Cos., Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios STAA or COO?
STAAR Surgical Co. quarterly revenues are $94.7M, which are smaller than The Cooper Cos., Inc. quarterly revenues of $1.1B. STAAR Surgical Co.'s net income of $8.9M is lower than The Cooper Cos., Inc.'s net income of $98.3M. Notably, STAAR Surgical Co.'s price-to-earnings ratio is 49.73x while The Cooper Cos., Inc.'s PE ratio is 37.92x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for STAAR Surgical Co. is 5.73x versus 3.82x for The Cooper Cos., Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income STAASTAAR Surgical Co.5.73x 49.73x $94.7M $8.9M COOThe Cooper Cos., Inc.3.82x 37.92x $1.1B $98.3M
-
Which has Higher Returns STAA or KIDS?
OrthoPediatrics Corp. has a net margin of 9.38% compared to STAAR Surgical Co.'s net margin of -19.22%. STAAR Surgical Co.'s return on equity of -25.83% beat OrthoPediatrics Corp.'s return on equity of -12.83%.
Company Gross Margin Earnings Per Share Invested Capital STAASTAAR Surgical Co.80.89% $0.18 $392.9M KIDSOrthoPediatrics Corp.65.27% -$0.50 $450.1M -
What do Analysts Say About STAA or KIDS?
STAAR Surgical Co. has a consensus price target of $25.88, signalling downside risk potential of -2.73%. On the other hand OrthoPediatrics Corp. has an analysts' consensus of $24.14 which suggests that it could grow by 32.87%. Given that OrthoPediatrics Corp. has higher upside potential than STAAR Surgical Co., analysts believe OrthoPediatrics Corp. is more attractive than STAAR Surgical Co..
Company Buy Ratings Hold Ratings Sell Ratings STAASTAAR Surgical Co.1 10 0 KIDSOrthoPediatrics Corp.3 1 0 -
Is STAA or KIDS More Risky?
STAAR Surgical Co. has a beta of 1.008, which suggesting that the stock is 0.806% more volatile than S&P 500. In comparison OrthoPediatrics Corp. has a beta of 1.062, suggesting its more volatile than the S&P 500 by 6.186%.
-
Which is a Better Dividend Stock STAA or KIDS?
STAAR Surgical Co. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. OrthoPediatrics Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. STAAR Surgical Co. pays -- of its earnings as a dividend. OrthoPediatrics Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios STAA or KIDS?
STAAR Surgical Co. quarterly revenues are $94.7M, which are larger than OrthoPediatrics Corp. quarterly revenues of $61.3M. STAAR Surgical Co.'s net income of $8.9M is higher than OrthoPediatrics Corp.'s net income of -$11.8M. Notably, STAAR Surgical Co.'s price-to-earnings ratio is 49.73x while OrthoPediatrics Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for STAAR Surgical Co. is 5.73x versus 1.87x for OrthoPediatrics Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income STAASTAAR Surgical Co.5.73x 49.73x $94.7M $8.9M KIDSOrthoPediatrics Corp.1.87x -- $61.3M -$11.8M
-
Which has Higher Returns STAA or LUCY?
Innovative Eyewear, Inc. has a net margin of 9.38% compared to STAAR Surgical Co.'s net margin of -274.85%. STAAR Surgical Co.'s return on equity of -25.83% beat Innovative Eyewear, Inc.'s return on equity of -80%.
Company Gross Margin Earnings Per Share Invested Capital STAASTAAR Surgical Co.80.89% $0.18 $392.9M LUCYInnovative Eyewear, Inc.36.64% -$0.38 $10.4M -
What do Analysts Say About STAA or LUCY?
STAAR Surgical Co. has a consensus price target of $25.88, signalling downside risk potential of -2.73%. On the other hand Innovative Eyewear, Inc. has an analysts' consensus of $3.00 which suggests that it could grow by 104.08%. Given that Innovative Eyewear, Inc. has higher upside potential than STAAR Surgical Co., analysts believe Innovative Eyewear, Inc. is more attractive than STAAR Surgical Co..
Company Buy Ratings Hold Ratings Sell Ratings STAASTAAR Surgical Co.1 10 0 LUCYInnovative Eyewear, Inc.0 0 0 -
Is STAA or LUCY More Risky?
STAAR Surgical Co. has a beta of 1.008, which suggesting that the stock is 0.806% more volatile than S&P 500. In comparison Innovative Eyewear, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock STAA or LUCY?
STAAR Surgical Co. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Innovative Eyewear, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. STAAR Surgical Co. pays -- of its earnings as a dividend. Innovative Eyewear, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios STAA or LUCY?
STAAR Surgical Co. quarterly revenues are $94.7M, which are larger than Innovative Eyewear, Inc. quarterly revenues of $668.1K. STAAR Surgical Co.'s net income of $8.9M is higher than Innovative Eyewear, Inc.'s net income of -$1.8M. Notably, STAAR Surgical Co.'s price-to-earnings ratio is 49.73x while Innovative Eyewear, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for STAAR Surgical Co. is 5.73x versus 2.00x for Innovative Eyewear, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income STAASTAAR Surgical Co.5.73x 49.73x $94.7M $8.9M LUCYInnovative Eyewear, Inc.2.00x -- $668.1K -$1.8M
-
Which has Higher Returns STAA or NXGL?
NexGel, Inc. has a net margin of 9.38% compared to STAAR Surgical Co.'s net margin of -22.05%. STAAR Surgical Co.'s return on equity of -25.83% beat NexGel, Inc.'s return on equity of -51.15%.
Company Gross Margin Earnings Per Share Invested Capital STAASTAAR Surgical Co.80.89% $0.18 $392.9M NXGLNexGel, Inc.40.93% -$0.08 $8.8M -
What do Analysts Say About STAA or NXGL?
STAAR Surgical Co. has a consensus price target of $25.88, signalling downside risk potential of -2.73%. On the other hand NexGel, Inc. has an analysts' consensus of $6.00 which suggests that it could grow by 265.85%. Given that NexGel, Inc. has higher upside potential than STAAR Surgical Co., analysts believe NexGel, Inc. is more attractive than STAAR Surgical Co..
Company Buy Ratings Hold Ratings Sell Ratings STAASTAAR Surgical Co.1 10 0 NXGLNexGel, Inc.0 0 0 -
Is STAA or NXGL More Risky?
STAAR Surgical Co. has a beta of 1.008, which suggesting that the stock is 0.806% more volatile than S&P 500. In comparison NexGel, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock STAA or NXGL?
STAAR Surgical Co. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NexGel, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. STAAR Surgical Co. pays -- of its earnings as a dividend. NexGel, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios STAA or NXGL?
STAAR Surgical Co. quarterly revenues are $94.7M, which are larger than NexGel, Inc. quarterly revenues of $2.9M. STAAR Surgical Co.'s net income of $8.9M is higher than NexGel, Inc.'s net income of -$647K. Notably, STAAR Surgical Co.'s price-to-earnings ratio is 49.73x while NexGel, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for STAAR Surgical Co. is 5.73x versus 1.07x for NexGel, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income STAASTAAR Surgical Co.5.73x 49.73x $94.7M $8.9M NXGLNexGel, Inc.1.07x -- $2.9M -$647K
-
Which has Higher Returns STAA or PAHC?
Phibro Animal Health Corp. has a net margin of 9.38% compared to STAAR Surgical Co.'s net margin of 7.29%. STAAR Surgical Co.'s return on equity of -25.83% beat Phibro Animal Health Corp.'s return on equity of 24.77%.
Company Gross Margin Earnings Per Share Invested Capital STAASTAAR Surgical Co.80.89% $0.18 $392.9M PAHCPhibro Animal Health Corp.32.8% $0.65 $1.1B -
What do Analysts Say About STAA or PAHC?
STAAR Surgical Co. has a consensus price target of $25.88, signalling downside risk potential of -2.73%. On the other hand Phibro Animal Health Corp. has an analysts' consensus of $43.00 which suggests that it could grow by 5.47%. Given that Phibro Animal Health Corp. has higher upside potential than STAAR Surgical Co., analysts believe Phibro Animal Health Corp. is more attractive than STAAR Surgical Co..
Company Buy Ratings Hold Ratings Sell Ratings STAASTAAR Surgical Co.1 10 0 PAHCPhibro Animal Health Corp.0 2 0 -
Is STAA or PAHC More Risky?
STAAR Surgical Co. has a beta of 1.008, which suggesting that the stock is 0.806% more volatile than S&P 500. In comparison Phibro Animal Health Corp. has a beta of 0.771, suggesting its less volatile than the S&P 500 by 22.868%.
-
Which is a Better Dividend Stock STAA or PAHC?
STAAR Surgical Co. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Phibro Animal Health Corp. offers a yield of 1.18% to investors and pays a quarterly dividend of $0.12 per share. STAAR Surgical Co. pays -- of its earnings as a dividend. Phibro Animal Health Corp. pays out 40.46% of its earnings as a dividend. Phibro Animal Health Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios STAA or PAHC?
STAAR Surgical Co. quarterly revenues are $94.7M, which are smaller than Phibro Animal Health Corp. quarterly revenues of $363.9M. STAAR Surgical Co.'s net income of $8.9M is lower than Phibro Animal Health Corp.'s net income of $26.5M. Notably, STAAR Surgical Co.'s price-to-earnings ratio is 49.73x while Phibro Animal Health Corp.'s PE ratio is 24.51x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for STAAR Surgical Co. is 5.73x versus 1.19x for Phibro Animal Health Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income STAASTAAR Surgical Co.5.73x 49.73x $94.7M $8.9M PAHCPhibro Animal Health Corp.1.19x 24.51x $363.9M $26.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
How High Could NVIDIA Stock Go?
NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 62x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 38x
Buy
63
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 40x
Alerts
Buy
54
SMX alert for Dec 5
SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.
Sell
15
HOV alert for Dec 5
Hovnanian Enterprises, Inc. [HOV] is down 22.58% over the past day.
Buy
67
NUTX alert for Dec 5
Nutex Health, Inc. [NUTX] is up 18.9% over the past day.
